Pubdate: Thu, 31 Jan 2002
Source: Helsingin Sanomat International Edition (Finland)
Copyright: 2002 2000 Helsingin Sanomat
Contact:  http://www.helsinki-hs.net/
Details: http://www.mapinc.org/media/1158

DEADLY DRUG COMBINATION: ECSTASY AND ANTI-DEPRESSANTS

Four Young Users Die During One Year

Four young Finns are reported to have died of the combined effects of the 
drug ecstasy and pharmaceutical anti-depressants in the past year. There 
are no previous reports of such deaths in Finland, or elsewhere. Erkki 
Vuori, Professor of Forensic Medicine at the University of Helsinki, wrote 
in the journal Mediuutiset recently that no such cases have been reported 
in the international literature. Experts say that the combined use of 
ecstasy and anti-depressants could be a very Finnish phenomenon.

In Finland, many users of intoxicants appear to be especially prone to 
trying different combinations of drugs. "We have an exceptionally large 
amount of combined use of alcohol and pharmaceuticals, and this phenomenon 
has spread among users of illicit drugs", says Antti Jaaskelainen, forensic 
pathologist for the Province of West Finland. Jaaskelainen has studied the 
recent deaths, one of which occurred in Turku and the rest in the Helsinki 
region. "Perhaps the deaths in Finland are not quite unique, but the use of 
many drugs is a Finnish phenomenon. Now we are wondering what might be 
done", Jaaskelainen sighs.

Each of the four deaths involved the same combination: in addition to 
ecstasy, users have taken the anti-depressant Aurorix(R). Two young users 
died after taking such a combination about a year ago, and two others about 
two months ago. Ecstasy, a drug with both stimulant and psychedelic 
properties, is generally used by recreational drug users rather than 
hard-core addicts.

The typical user is a young person seeking good feelings and the 
stimulation necessary for hours of dancing at "rave" parties. "Many ecstasy 
users are just becoming acquainted with drugs", says Antti Holopainen, head 
physician at the Jarvenpaa Addiction Hospital. He says that he has not seen 
many instances of combined use of ecstasy and anti-depressants. Holopainen 
adds that doctors and others working in drug rehabilitation have known for 
years of the dangers of combining Aurorix(R) and amphetamines. 
"Anti-depressants combined with ecstasy can lead to a so-called serotonin 
syndrome.

Aurorix(R) is the most dangerous of the substances", Holopainen says.

What is especially alarming in Holopainen's view is that the use of ecstasy 
in itself eventually leads to a gloomy phase, which young users try to 
counter with anti-depressants sold on the black market. This is apparently 
what happened in each of the deaths that have come to light. Holopainen 
warns that ecstasy is not as harmless a stimulant as some young users seem 
to think. "Contrary to what is generally believed, occasional use can lead 
to addiction and to organic changes in the brain.

Especially skills linked with learning can deteriorate." Some have taken 
anti-depressants specifically to boost the effects of the ecstasy.

There has been plenty of discussion in Internet chat rooms on ways to boost 
the effects of "e".

On the other hand news of the four deaths has awoken concern among users of 
ecstasy. For instance, many questions on the combined effects of ecstasy 
and anti-depressants have been posted on the web site of the A-Clinic 
Foundation in recent days. "I have suggested that we post clear 
instructions on what substances should not be combined", says project 
planner Lotta Lehmusvaara of the A-Clinic Foundation. "The experts have 
been so busy that no instructions have been written yet." On Wednesday the 
A-Clinic Foundation web site was not working. "It seems that some hacker 
crashed the whole server on Tuesday", says Rauno Makela, head physician at 
the A-Clinic Foundation.

Links: DrugScope (UK) drug database - Ecstasy

Aurorix (R) information
- ---
MAP posted-by: Jay Bergstrom